News - Page 2 of 49

Post

Strengthening the European Psychedelic Ecosystem: Partnership Between Octarine Bio and Clerkenwell Health

Patient Access

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. Clerkenwell Health … Continued

Post

Opinion: Patel’s Proposed Nitrous Oxide Ban Increases Risks for Young People

General Advocacy

Home Secretary Priti Patel last week formally asked the Advisory Council on the Misuse of Drugs (ACMD) to “review the harm caused by nitrous oxide”, announcing that the unlawful possession of nitrous oxide could be made a crime in England and Wales. Patel claimed that “protect[ing] the futures of our children and young people” was … Continued

Post

Grow Group, a Leading Medical Cannabis Company, Launches Successful Crowdfunder

Patient Access

Leading medical cannabis provider Grow Group Plc has been raising on the crowdfunding platform Seedrs throughout August. So far they’ve had over 500 new investors invest in their company. Grow created the campaign to seek investment from ‘socially conscious shareholders’ in order to expand operations and hire new staff, attempting to expand the 1,200 medical … Continued

Post

Opinion: Why the Cannabis Sector Needs Feminising

Cannabis 2.0

We know a lot about cannabis. Anecdotally, through academic studies, and even Seth Rogen & Snoop Dogg’s twitter accounts. However, women’s relationship to and use patterns with cannabis are rarely discussed. Women’s pain is internal and inherent. We are directed as a first port of call toward medicines that carry risks of blood clots higher … Continued

Post

Opinion: Psychedelic Decriminalisation Only Scratches the Surface

General Advocacy

Decriminalising psychedelic drugs is undoubtedly an important step for social justice. However, there is a much larger issue that needs to be addressed for the psychedelic movement. To see real and widespread change, psychedelic drugs must be accepted in the mainstream medical framework with regulatory clarity setting out a structured pathway. Decriminalisation is necessary but … Continued

Post

Tragic Deaths in London & Bristol as Clubs Reopen Across the UK

General Advocacy

The return of night life sadly comes with the return of increased drug-related harm. Over the weekend two young people died in Bristol and London from preventable drug-related deaths linked to what is believed to be high strength MDMA pills. With several hospitalisations there has been an increased concern over these not being isolated incidents. … Continued

Post

The Response to Dame Black’s Review Misses the Mark

General Advocacy

The government last week released their official response to Dame Carol Black’s Independent Review of Drugs parts one and two, a disappointing culmination of the insightful work of Dame Black on the matter since February 2019. The response by Health Secretary Sajid Javid, Home Secretary Priti Patel, and Sponsor Minister for Combating Drug Misuse Kit … Continued

Post

Impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within homeless population

General Advocacy

The Psychoactive Substances Act (PSA) was introduced in 2016, making the production or supply of any chemical substances that may be used for its psychoactive effects a criminal offence. The introduction of this law was in response to growing concerns over the grey area through which New Psychoactive Substances (NPS) were legally being sold in … Continued

Post

Opinion: Sha’Carri Richardson’s Olympics Ban Demonstrates There is Still Work to be Done to Change Public Opinion on Cannabis Usage

Cannabis 2.0

When discussing cannabis reform, it’s often in relation to the immediate spheres of society, where prohibition has taken priority over harm reduction, and consumers are at immediate risk of harms perpetuated by existing policy. Undoubtedly this is an important focal point, especially in the UK where we still have some way to go with respect … Continued

Post

Volteface Interview: The High Minds Brand with Danielle Morgan

Cannabis 2.0

Cannabis is being progressively recontextualised through innovative design solutions, helping to clean up the heavily stigmatised image of the plant. Volteface’s Katya Kowalski interviewed Danielle Morgan, founder of High Minds, a newly launched Irish cannabis lifestyle brand and online store. What got you interested in the cannabis space in the first place? I was brought … Continued